Matthew Del Giudice - Aug 27, 2024 Form 4 Insider Report for Telomir Pharmaceuticals, Inc. (TELO)

Role
Director
Signature
/s/ Matthew Del Giudice
Stock symbol
TELO
Transactions as of
Aug 27, 2024
Transactions value $
$0
Form type
4
Date filed
8/29/2024, 04:05 PM
Previous filing
Aug 15, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELO Incentive Stock Options (right to buy) Award $0 +25K $0.00 25K Aug 27, 2024 Common Stock 25K $5.02 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 26, 2024.
F2 The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025.